Foley Special Counsel Benjamin Daniels will be presenting on Tuesday, June 26, 2018 at the AHLA Annual Meeting. His presentation is titled “Legal Issues Affecting Pharmacies-A Look at Mishaps and Enforcement Actions in the Pharmacy Industry.”
Daniels is presenting with Lindsay P. Holmes, Associate for Baker Hostetler. Their presentation will cover the following:
- Pharmacy practice and common areas of concern related to compliance
- Legal issues related to enforcement actions pharmacies encounter, including state enforcement (e.g., state boards of pharmacy) and federal enforcement (e.g., DEA, OIG, FDA)
- Legal issues related to adverse contractual actions (e.g., payer audits and charge backs)
- Strategies for handling enforcement actions for pharmacy clients
To learn more and register, visit the AHLA website.
Related Insights
24 July 2025
Events
ACI's Inaugural Summit on GLP-1 Law & Policy
Foley partner Kyle Faget, co-chair of the firm’s Medical Devices Area of Focus, is speaking in American Conference Institute’s Inaugural Summit on GLP-1 Law & Policy on July 24.
23 April 2025
Tariff & International Trade Resource
What Every Multinational Company Should Know About…Tariff Strategies for Sell-Side Contracts
With the size and scope of President Trump’s tariffs continuing to shift, this is a critical time for businesses to assess their contracts and determine how increased tariff costs might adversely affect profitability, and whether there are any strategies to mitigate the losses.
22 April 2025
Health Care Law Today
Health Care Marketing: The Seventh Circuit Addresses “Referrals” Under The Anti-Kickback Statute
The case, United States v. Sorenson, addressed whether a Medicare-registered distributor violated the AKS in making payments to advertising, marketing, and manufacturing companies that worked to sell orthopedic braces to Medicare patients. The court held that such payments were not “referrals” within the meaning of the AKS because the payments were made to entities that were neither physicians in a position to refer their patients nor other decisionmakers in positions to “leverage fluid, informal power and influence” over health care decisions.